nuclear energy

Constellation Energy beat revenue expectations at $6.07B, driven by nuclear and renewable output. Announced 10% dividend increase, boosting stock 5.74%.

NuScale Power stock plummeted 77% amid market concerns about small reactor viability, despite securing regulatory approval for a Romania project expected online in 2033.

Centrus Energy, sole U.S. HALEU producer, poised to benefit from nuclear expansion driven by AI data centers. Stock up 83% with $2.3B order backlog.

Vistra Energy fell below $200 after tripling in three years. Low dividend yield of 0.54% offset by strong 10.7% annual growth and conservative payout ratio.

NuScale and Oklo compete in SMRs with different strategies: NuScale secured regulatory approval for faster deployment, while Oklo pursues vertical integration through fuel technology acquisition.

NuScale Power, the only U.S.-approved small modular reactor developer, faces profitability challenges despite promising nuclear technology and surging data center demand, but lacks firm customer contracts.

Nano Nuclear's CEO sold $30M in shares through a pre-planned trading arrangement, reducing his stake by 9.24% amid company's early-stage microreactor development.

Oklo stock surged 558% over five years as the advanced nuclear reactor developer secured DOE funding. The pre-revenue company faces commercialization risks despite strong investor interest in SMR technology.

Nano Nuclear Energy stock rose 1.03% after reporting Q1 loss of 13 cents per share, beating expectations of 29 cents and signaling improved operational efficiency.

AI data center demand and Trump's nuclear expansion policy create supply deficit, boosting uranium suppliers. DOE's $2.7B investment strengthens domestic fuel capacity and market opportunities.

Constellation Energy fell 32% amid rate cap concerns, but benefits from strong tech demand and long-term power contracts that provide revenue visibility and growth potential.

NuScale Power's stock plummeted 75% as the SMR developer faces profitability challenges, delayed commercialization timelines, and a major project write-down amid investor skepticism.

NuScale Power gains NRC approval for SMR technology but faces high valuation at 70x sales with no commercial deployment yet, making it a speculative pre-revenue investment.

Fermi Inc. faces securities fraud lawsuit over Project Matador disclosures, alleging misrepresentation of tenant commitments. Stock fell 33% after primary tenant withdrew funding in December 2025.